de Silva J A, Munno N, D'Arconte L, Strojny N
J Pharm Sci. 1978 Jun;67(6):752-6. doi: 10.1002/jps.2600670605.
Sensitive and specific spectrofluorometric assays were developed for the determination of d, 1-4-(3,4-dimethoxybenzyl)-2-imidazolidinone and d,1-4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in blood and urine. Each compound is selectively extracted from buffered blood or urine and oxidized with alkaline permanganate to its respective fluorescent benzoic acid derivative, which is quantitated in acetic acid in ethanol (1:99). The method was applied to the determination of blood levels and urinary excretion in the dog following the administration of single intravenous and oral doses of each compound.
开发了灵敏且特异的荧光分光光度法,用于测定血液和尿液中的d,1-4-(3,4-二甲氧基苄基)-2-咪唑烷酮和d,1-4-(3-丁氧基-4-甲氧基苄基)-2-咪唑烷酮。每种化合物从缓冲的血液或尿液中选择性萃取,并用碱性高锰酸钾氧化为各自的荧光苯甲酸衍生物,该衍生物在乙醇(1:99)的乙酸中进行定量。该方法应用于犬单次静脉内和口服给予每种化合物后血液水平和尿排泄的测定。